Abstract |
Molecularly targeted therapies for advanced prostate cancer include castration modalities that suppress ligand-dependent transcriptional activity of the androgen receptor (AR). However, persistent AR signalling undermines therapeutic efficacy and promotes progression to lethal castration-resistant prostate cancer (CRPC), even when patients are treated with potent second-generation AR-targeted therapies abiraterone and enzalutamide. Here we define diverse AR genomic structural rearrangements (AR-GSRs) as a class of molecular alterations occurring in one third of CRPC-stage tumours. AR-GSRs occur in the context of copy-neutral and amplified AR and display heterogeneity in breakpoint location, rearrangement class and sub-clonal enrichment in tumours within and between patients. Despite this heterogeneity, one common outcome in tumours with high sub-clonal enrichment of AR-GSRs is outlier expression of diverse AR variant species lacking the ligand-binding domain and possessing ligand-independent transcriptional activity. Collectively, these findings reveal AR-GSRs as important drivers of persistent AR signalling in CRPC.
|
Authors | Christine Henzler, Yingming Li, Rendong Yang, Terri McBride, Yeung Ho, Cynthia Sprenger, Gang Liu, Ilsa Coleman, Bryce Lakely, Rui Li, Shihong Ma, Sean R Landman, Vipin Kumar, Tae Hyun Hwang, Ganesh V Raj, Celestia S Higano, Colm Morrissey, Peter S Nelson, Stephen R Plymate, Scott M Dehm |
Journal | Nature communications
(Nat Commun)
Vol. 7
Pg. 13668
(11 29 2016)
ISSN: 2041-1723 [Electronic] England |
PMID | 27897170
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- AR protein, human
- RNA, Messenger
- Receptors, Androgen
|
Topics |
- Alleles
- Cell Line, Tumor
- Chromosomes, Human, Pair 11
(genetics)
- Clone Cells
- Exons
(genetics)
- Gene Dosage
- Gene Expression Regulation, Neoplastic
- Gene Rearrangement
(genetics)
- Genome, Human
- Humans
- Male
- Neoplasm Metastasis
- Prostatic Neoplasms, Castration-Resistant
(genetics)
- RNA, Messenger
(genetics, metabolism)
- Receptors, Androgen
(metabolism)
|